1-[(3S,5S,8S,9R,10R,12R,13R,14R,17S)-5,8,14,17-tetrahydroxy-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4R,5R,6R)-5-[(2S,3R,4S,5R,6R)-3-hydroxy-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-12-[(E)-3-phenylprop-2-enoyl]oxy-2,3,4,9,11,12,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl benzoate

Details

Top
Internal ID 182189a6-5aac-4734-bbd3-5ce1395dfa1f
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides
IUPAC Name 1-[(3S,5S,8S,9R,10R,12R,13R,14R,17S)-5,8,14,17-tetrahydroxy-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4R,5R,6R)-5-[(2S,3R,4S,5R,6R)-3-hydroxy-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-12-[(E)-3-phenylprop-2-enoyl]oxy-2,3,4,9,11,12,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl benzoate
SMILES (Canonical) CC1C(C(CC(O1)OC2CCC3(C4CC(C5(C(CCC5(C4(C=CC3(C2)O)O)O)(C(C)OC(=O)C6=CC=CC=C6)O)C)OC(=O)C=CC7=CC=CC=C7)C)OC)OC8CC(C(C(O8)C)OC9CC(C(C(O9)C)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)O)O)OC)O)OC)OC
SMILES (Isomeric) C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@@]3([C@H]4C[C@H]([C@@]5([C@@](CC[C@@]5([C@@]4(C=C[C@]3(C2)O)O)O)(C(C)OC(=O)C6=CC=CC=C6)O)C)OC(=O)/C=C/C7=CC=CC=C7)C)OC)O[C@H]8C[C@@H]([C@@H]([C@H](O8)C)O[C@H]9C[C@H]([C@@H]([C@H](O9)C)O[C@H]1[C@@H]([C@@H]([C@@H]([C@H](O1)C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)OC)O)OC)OC
InChI InChI=1S/C71H102O27/c1-36-58(95-52-31-45(84-9)59(37(2)88-52)96-53-32-46(85-10)60(38(3)89-53)97-65-57(77)62(86-11)61(39(4)90-65)98-64-56(76)55(75)54(74)47(35-72)93-64)44(83-8)30-51(87-36)92-43-24-25-66(6)48-33-49(94-50(73)23-22-41-18-14-12-15-19-41)67(7)69(80,40(5)91-63(78)42-20-16-13-17-21-42)28-29-71(67,82)70(48,81)27-26-68(66,79)34-43/h12-23,26-27,36-40,43-49,51-62,64-65,72,74-77,79-82H,24-25,28-35H2,1-11H3/b23-22+/t36-,37-,38-,39-,40?,43+,44+,45+,46-,47-,48-,49-,51+,52+,53+,54-,55+,56-,57-,58-,59-,60-,61-,62+,64+,65+,66-,67-,68-,69-,70+,71-/m1/s1
InChI Key ATSQTDGTTSBCIO-KDBYNGFGSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C71H102O27
Molecular Weight 1387.50 g/mol
Exact Mass 1386.66084797 g/mol
Topological Polar Surface Area (TPSA) 364.00 Ų
XlogP 2.70
Atomic LogP (AlogP) 2.66
H-Bond Acceptor 27
H-Bond Donor 9
Rotatable Bonds 21

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 1-[(3S,5S,8S,9R,10R,12R,13R,14R,17S)-5,8,14,17-tetrahydroxy-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4R,5R,6R)-5-[(2S,3R,4S,5R,6R)-3-hydroxy-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-12-[(E)-3-phenylprop-2-enoyl]oxy-2,3,4,9,11,12,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl benzoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6693 66.93%
Caco-2 - 0.8586 85.86%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability - 0.8571 85.71%
Subcellular localzation Mitochondria 0.7281 72.81%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8126 81.26%
OATP1B3 inhibitior + 0.8952 89.52%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7000 70.00%
BSEP inhibitior + 0.9798 97.98%
P-glycoprotein inhibitior + 0.7436 74.36%
P-glycoprotein substrate + 0.7700 77.00%
CYP3A4 substrate + 0.7463 74.63%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8853 88.53%
CYP3A4 inhibition - 0.7290 72.90%
CYP2C9 inhibition - 0.9220 92.20%
CYP2C19 inhibition - 0.9292 92.92%
CYP2D6 inhibition - 0.9558 95.58%
CYP1A2 inhibition - 0.9008 90.08%
CYP2C8 inhibition + 0.8226 82.26%
CYP inhibitory promiscuity - 0.9629 96.29%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6681 66.81%
Eye corrosion - 0.9923 99.23%
Eye irritation - 0.8966 89.66%
Skin irritation - 0.6509 65.09%
Skin corrosion - 0.9479 94.79%
Ames mutagenesis - 0.6540 65.40%
Human Ether-a-go-go-Related Gene inhibition + 0.7995 79.95%
Micronuclear - 0.7500 75.00%
Hepatotoxicity - 0.6137 61.37%
skin sensitisation - 0.9343 93.43%
Respiratory toxicity + 0.6778 67.78%
Reproductive toxicity + 0.8556 85.56%
Mitochondrial toxicity + 0.7125 71.25%
Nephrotoxicity - 0.9832 98.32%
Acute Oral Toxicity (c) I 0.5692 56.92%
Estrogen receptor binding + 0.6711 67.11%
Androgen receptor binding + 0.7679 76.79%
Thyroid receptor binding + 0.7497 74.97%
Glucocorticoid receptor binding + 0.8136 81.36%
Aromatase binding + 0.6846 68.46%
PPAR gamma + 0.8117 81.17%
Honey bee toxicity - 0.6371 63.71%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity + 0.5745 57.45%
Fish aquatic toxicity + 0.9742 97.42%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.87% 91.11%
CHEMBL1293249 Q13887 Kruppel-like factor 5 98.50% 86.33%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 97.20% 96.00%
CHEMBL4302 P08183 P-glycoprotein 1 96.86% 92.98%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.66% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.77% 97.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.40% 95.56%
CHEMBL226 P30542 Adenosine A1 receptor 93.93% 95.93%
CHEMBL2716 Q8WUI4 Histone deacetylase 7 91.49% 89.44%
CHEMBL2581 P07339 Cathepsin D 90.96% 98.95%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.50% 89.00%
CHEMBL221 P23219 Cyclooxygenase-1 90.34% 90.17%
CHEMBL216 P11229 Muscarinic acetylcholine receptor M1 90.10% 94.23%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 89.10% 95.17%
CHEMBL5028 O14672 ADAM10 88.35% 97.50%
CHEMBL3475 P05121 Plasminogen activator inhibitor-1 87.64% 83.00%
CHEMBL4227 P25090 Lipoxin A4 receptor 87.60% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 87.40% 95.89%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 86.83% 95.50%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 85.17% 95.89%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 84.65% 93.00%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 84.44% 92.62%
CHEMBL1994 P08235 Mineralocorticoid receptor 83.70% 100.00%
CHEMBL3714130 P46095 G-protein coupled receptor 6 83.06% 97.36%
CHEMBL2335 P42785 Lysosomal Pro-X carboxypeptidase 82.78% 100.00%
CHEMBL3359 P21462 Formyl peptide receptor 1 82.68% 93.56%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 82.14% 99.23%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 82.11% 97.14%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 81.79% 96.47%
CHEMBL3060 Q9Y345 Glycine transporter 2 81.35% 99.17%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 81.25% 94.08%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 80.06% 94.62%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Gymnema sylvestre

Cross-Links

Top
PubChem 101948684
LOTUS LTS0028772
wikiData Q104918663